The New Generation Pan-Ppar Agonist Iva337 Protects the Liver from Metabolic Disorders and Fibrosis
Wettstein, G, Estivalet, C, Tessier, J, Boustugue, P.T, Jantzen, I, Defrene, E, Kupkowski, F, Faye, P, Adarbes, V, Germain, J.-M, Vasseur, E, Robert, C, Fromond, C, Broqua, P, Junien, J.-L, Luccarini, J.-M, Konstantinova, I
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
594 Identification of novel EZH2 inhibitor scaffolds
Espanel, X, Chene, L, Soude, A, Estevez, S, Adarbes, V, Loillier, B, Boubia, B, Masson, P, Montalbetti, C, Broqua, P, Fromond, C
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
PS068 - The New Generation Pan-Ppar Agonist Iva337 Protects the Liver from Metabolic Disorders and Fibrosis
Wettstein, G., Estivalet, C., Tessier, J., Boustugue, P.T., Jantzen, I., Defrene, E., Kupkowski, F., Faye, P., Adarbes, V., Germain, J.-M., Vasseur, E., Robert, C., Fromond, C., Broqua, P., Junien, J.-L., Luccarini, J.-M., Konstantinova, I.
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article